Preclinical Evaluation of the HIV-1 Fusion Inhibitor L'644 as a Potential Candidate Microbicide

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.06108-11
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Punica Granatum(Pomegranate) Juice Provides an HIV-1 Entry Inhibitor and Candidate Topical Microbicide

BMC Infectious Diseases
Infectious Diseases
2004English

Non-Aqueous Silicone Elastomer Gels as a Vaginal Microbicide Delivery System for the HIV-1 Entry Inhibitor Maraviroc

Journal of Controlled Release
Pharmaceutical Science
2011English

Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

L-696,474, a Novel Cytochalasin as an Inhibitor of HIV-1 Protease. III. Biological Activity.

Journal of Antibiotics
Drug DiscoveryPharmacology
1992English

Peptides and Peptidomimetics as Tools to Probe Protein-Protein Interactions – Disruption of HIV-1 Gp41 Fusion Core and Fusion Inhibitor Design

2012English

The Inhibitor Apoptosis Protein Antagonist Debio 1143 Is an Attractive HIV-1 Latency Reversal Candidate

PLoS ONE
Multidisciplinary
2019English

Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America

New England Journal of Medicine
Medicine
2003English

Homeostatic Properties of Lactobacillus Jensenii Engineered as a Live Vaginal Anti-Hiv Microbicide

BMC Microbiology
Microbiology
2013English

Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy